Prostate Cancer Questions and Answers

You are invited to ask about your or your loved one’s prostate cancer.  Prostate Cancer Questions and Answers gives you access to advice from America’s leading oncology focused specialists. Malecare is one of the world’s leading prostate cancer support and advocacy nonprofit organizations. Our colleagues are here to help you.  Doctors volunteering their time to answer your questions.  Please feel encouraged to click (on their photo’s) and ask. Please note that we are currently (January 2010) experiencing a significant backlog of questions; so many of you are asking prostate cancer questions worthy of well considered answers….please continue to ask, but, also, please be patient. We’ll email you when your question is replied to.

Ask Dr. Espinosa

Geo Espinosa, N.D., L.Ac, CNS, RH (AHG) is the Director of the Integrative Urological Center at New York University Langone Medical Center. Before joining NYU, Dr. Espinosa was a clinician, researcher and director of clinical trials at the Center for Holistic Urology at Columbia University Medical Center. He is a licensed naturopathic doctor, licensed acupuncturist, a Certified Nutrition Specialist and a Registered Herbalist. Dr. Espinosa is an author of the naturopathic entry in 1000 Cures for 200 ailments, by Harper Collins; March 2007 and “Prostate cancer – Nutrients that may slow its progression,” Food and Nutrients in Disease Management - Maryland: Cadmus Publishing, 2009.

Ask Dr. Myers

Medical oncologist and prostate cancer survivor, Dr Charles "Snuffy" Myers was a key player in creating AZT, Suranim, and Phenylacetate while working at the National Institute of Health. With over 250 research papers published, Myers is one of the leading developers of today's prostate cancer canon on both the research and treatment side of the test tube. Former Cancer Director at the University of Virginia, Myers opened the American Institute for Diseases of the Prostate in 2002 to provide men with the kind of comprehensive care that saved his own life. Dr. Myers has long been popular among prostate cancer patients as a speaker because of his ability to explain science and medicine in easy-to-understand language.

Ask Dr. Petrylak

Daniel P. Petrylak, M.D., Associate Professor of Medicine, and Program Director of the Genitourinary Oncology Section in the Division of Hematology/Oncology, Department of Medicine, Columbia University Medical Center. Dr. Petrylak is involved in clinical trials research on national and international levels. He served as the Principle Investigator for a randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone in men with hormone refractory prostate cancer. This trial was one of two studies that demonstrated a survival benefit for docetaxel-based therapy in men with advanced prostate cancer. This trial supported the approval of docetaxel by the FDA.